XORTX Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc cash flow reinvestment rate. XORTX Therapeutics Inc (XRTX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting CA$5.68K (capex CA$2.84K plus investments CA$-2.84K) from operating cash flow of CA$1.57 Million. Explore XRTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$5.68K

Capex + Investments

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

Cash Flow Reinvestment Rate of XORTX Therapeutics Inc (2017–2017)

Cash flow reinvestment rate of XORTX Therapeutics Inc from 2017 to 2017. Historical reinvestment intensity for XORTX Therapeutics Inc across 1 annual periods. Explore XORTX Therapeutics Inc (XRTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

XORTX Therapeutics Inc Cash Flow Reinvestment Rate by Year (2017–2017)

XORTX Therapeutics Inc cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for XORTX Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does XORTX Therapeutics Inc generate cash.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2017	0.01x	CA$1.17K	CA$91.17K	CA$1.17K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow